Insights

How Edge AI is transforming pharmaceutical line clearance

Mike Sales

Mike Sales

Principal Consultant – Head of AI

Line clearance is one of the most critical and time-consuming steps in pharmaceutical manufacturing and other regulated industries such as medical devices, and food and beverage. 

It’s traditionally done through multiple manual inspections to ensure all materials, products, labels, and records from a previous batch have been completely removed from the line before starting the next one.  But with growing product customisation, batch sizes shrinking and the number of changeovers increasing, the limitations of manual checks are becoming crystal clear.

A new generation of edge AI technologies is now making it possible to automate line-clearance inspections more securely, cost-effectively, and at scale.

In a recent article for Vision Spectra magazine, Mike Sales, Head of AI at 42T explains that while the pressures on production teams haven’t changed, the tools available to them have evolved.

With the latest advances in deep learning, neural-processing silicon and no-code model training tools, automation can now finally tackle the long-standing pain point of manual line clearance.

The key messages from Mike’s article are clear:

  • Manual line clearance is no longer sustainable. Increasing numbers of personalised and customised products are leading to more frequent changeovers and increasing the risk of human error.
  • Traditional automation approaches are too expensive. High hardware costs, complex integration, and the need for extensive training all stand in the way of the established solutions.
  • Edge AI provides a secure, high-performance alternative. Deep-learning models run on local devices without needing cloud connectivity, meaning they’re secure and efficient by design.

As Edge AI advances, it seems set to become the new standard.

New NPU-enabled silicon offers outstanding performance at a fraction of the cost of high-end dedicated platforms; while Multimodal edge AI provides continuous value as the same cameras can perform line clearance, as well as real-time defect detection, anomaly detection, and product tracking.

Decentralised architectures reduce integration complexity and cost, and no-code model training removes a major barrier enabling operators to build and retrain models on-site without needing specialist expertise.

This outstanding performance means thatregulatory acceptance is growing, with early adopters already demonstrating that automated inspection can meet validation requirements. The result sets a new benchmark for manufacturing efficiency by improving uptime and  yields, reducing costs, and boosting product integrity across production lines.


As published in Vision Spectra, Spring Issue 2026